Found: 174
Select item for more details and to access through your institution.
Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines.
- Published in:
- 2019
- By:
- Publication type:
- journal article
CCDC78 : Unveiling the Function of a Novel Gene Associated with Hereditary Myopathy.
- Published in:
- Cells (2073-4409), 2024, v. 13, n. 17, p. 1504, doi. 10.3390/cells13171504
- By:
- Publication type:
- Article
Adult onset Niemann-Pick type C disease: A clinical, neuroimaging and molecular genetic study.
- Published in:
- Movement Disorders, 2003, v. 18, n. 11, p. 1405, doi. 10.1002/mds.10541
- By:
- Publication type:
- Article
Novel Biomarkers for Limb Girdle Muscular Dystrophy (LGMD).
- Published in:
- Cells (2073-4409), 2024, v. 13, n. 4, p. 329, doi. 10.3390/cells13040329
- By:
- Publication type:
- Article
The Role of TNF-α in Alzheimer's Disease: A Narrative Review.
- Published in:
- Cells (2073-4409), 2024, v. 13, n. 1, p. 54, doi. 10.3390/cells13010054
- By:
- Publication type:
- Article
Current Evidence Supporting the Role of Immune Response in ATTRv Amyloidosis.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 19, p. 2383, doi. 10.3390/cells12192383
- By:
- Publication type:
- Article
Serum Inflammatory Profile in Hereditary Transthyretin Amyloidosis: Mechanisms and Possible Therapeutic Implications.
- Published in:
- Brain Sciences (2076-3425), 2022, v. 12, n. 12, p. 1708, doi. 10.3390/brainsci12121708
- By:
- Publication type:
- Article
Disease progression in the first 5 years of treatment in multiple sclerosis: Predictive value of early brain and lesion volume changes.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 44, doi. 10.1177/13524585231212879
- By:
- Publication type:
- Article
Paramagnetic rims are a promising diagnostic imaging biomarker in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 14, p. 2212, doi. 10.1177/13524585221118677
- By:
- Publication type:
- Article
Clinically relevant profiles of myelin content changes in patients with multiple sclerosis: A multimodal and multicompartment imaging study.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 12, p. 1881, doi. 10.1177/13524585221096975
- By:
- Publication type:
- Article
Characterizing 1-year development of cervical cord atrophy across different MS phenotypes: A voxel-wise, multicentre analysis.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 6, p. 885, doi. 10.1177/13524585211045545
- By:
- Publication type:
- Article
Analysis of frequency and severity of relapses in multiple sclerosis patients treated with cladribine tablets or placebo: The CLARITY and CLARITY Extension studies.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 1, p. 111, doi. 10.1177/13524585211010294
- By:
- Publication type:
- Article
Mild gray matter atrophy in patients with long-standing multiple sclerosis and favorable clinical course.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 1, p. 154, doi. 10.1177/13524585211019650
- By:
- Publication type:
- Article
Gray matter atrophy cannot be fully explained by white matter damage in patients with MS.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 1, p. 39, doi. 10.1177/1352458519900972
- By:
- Publication type:
- Article
Response to Dr Boyko's letter: 'Radiologically isolated syndrome with oligoclonal bands in CSF (RIS + OCB) can be classified as highly MS-risk group'.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Reduced dynamics of functional connectivity and cognitive impairment in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 4, p. 476, doi. 10.1177/1352458519837707
- By:
- Publication type:
- Article
Pathological cut-offs of global and regional brain volume loss in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 4, p. 541, doi. 10.1177/1352458517742739
- By:
- Publication type:
- Article
Validating the use of brain volume cutoffs to identify clinically relevant atrophy in RRMS.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 2, p. 217, doi. 10.1177/1352458517743804
- By:
- Publication type:
- Article
Response to ‘Does cladribine have an impact on brain atrophy in people with relapsing remitting multiple sclerosis?’ by Schiffmann et al.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 2, p. 214, doi. 10.1177/1352458517717808
- By:
- Publication type:
- Article
Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 2, p. 222, doi. 10.1177/1352458517690269
- By:
- Publication type:
- Article
Imaging outcome measures for progressive multiple sclerosis trials.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 14, p. 1614, doi. 10.1177/1352458517729456
- By:
- Publication type:
- Article
Pronounced structural and Functional Damage in early adult Pediatric-Onset Multiple sclerosis with no or Minimal clinical Disability.
- Published in:
- Frontiers in Neurology, 2017, p. 1, doi. 10.3389/fneur.2017.00608
- By:
- Publication type:
- Article
Changes in grey matter volume and functional connectivity in cluster headache versus migraine.
- Published in:
- 2020
- By:
- Publication type:
- journal article
DTI-derived indexes of brain WM correlate with cognitive performance in vascular MCI and small-vessel disease. A TBSS study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Assessing Neuronal Metabolism In Vivo by Modeling Imaging Measures.
- Published in:
- Journal of Neuroscience, 2010, v. 30, n. 45, p. 15030, doi. 10.1523/JNEUROSCI.3330-10.2010
- By:
- Publication type:
- Article
(DXT49) Post Hoc Analysis of Efficacy of Cladribine Tablets in Patients with Relapsing-Remitting Multiple Sclerosis Aged Over and Under 30 Years in the CLARITY Study.
- Published in:
- International Journal of MS Care, 2020, v. 22, n. S2, p. 33
- By:
- Publication type:
- Article
(DXT48) Efficacy of Subcutaneous Interferon Beta-1a in Patients with a First Clinical Demyelinating Event: REFLEX Study -- Outcomes in Patients Stratified by 2017 McDonald Criteria.
- Published in:
- International Journal of MS Care, 2020, v. 22, n. S2, p. 33
- By:
- Publication type:
- Article
(DXT08) Post Hoc Analysis of Efficacy of Cladribine Tablets in Patients with Relapsing-Remitting Multiple Sclerosis Diagnosed Within 3 or 4 Years Prior to the CLARITY Study.
- Published in:
- International Journal of MS Care, 2020, v. 22, n. S2, p. 18
- By:
- Publication type:
- Article
Methods for Brain Atrophy MR Quantification in Multiple Sclerosis: Application to the Multicenter INNI Dataset.
- Published in:
- Journal of Magnetic Resonance Imaging, 2023, v. 58, n. 4, p. 1221, doi. 10.1002/jmri.28616
- By:
- Publication type:
- Article
Automated identification of brain new lesions in multiple sclerosis using subtraction images.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Clinical use of brain volumetry.
- Published in:
- Journal of Magnetic Resonance Imaging, 2013, v. 37, n. 1, p. spcone, doi. 10.1002/jmri.23999
- By:
- Publication type:
- Article
Clinical use of brain volumetry.
- Published in:
- Journal of Magnetic Resonance Imaging, 2013, v. 37, n. 1, p. 1, doi. 10.1002/jmri.23671
- By:
- Publication type:
- Article
Intercenter differences in diffusion tensor MRI acquisition.
- Published in:
- Journal of Magnetic Resonance Imaging, 2010, v. 31, n. 6, p. 1458, doi. 10.1002/jmri.22186
- By:
- Publication type:
- Article
Measuring Brain Atrophy in Multiple Sclerosis.
- Published in:
- Journal of Neuroimaging, 2007, v. 17, p. 10S, doi. 10.1111/j.1552-6569.2007.00130.x
- By:
- Publication type:
- Article
MR Spectroscopy in Multiple Sclerosis.
- Published in:
- Journal of Neuroimaging, 2007, v. 17, p. 31S, doi. 10.1111/j.1552-6569.2007.00134.x
- By:
- Publication type:
- Article
Imaging outcome measures for progressive multiple sclerosis trials.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 12, p. 1614, doi. 10.1177/1352458517729456
- By:
- Publication type:
- Article
Advanced MRI measures like DTI or fMRI should be outcome measures in future clinical trials - Commentary.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
Defining brain volume cutoffs to identify clinically relevant atrophy in RRMS.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 5, p. 656, doi. 10.1177/1352458516659550
- By:
- Publication type:
- Article
Inclusion of brain volume loss in a revised measure of ‘no evidence of disease activity’ (NEDA-4) in relapsing–remitting multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 10, p. 1297, doi. 10.1177/1352458515616701
- By:
- Publication type:
- Article
Prognostic biomarkers of IFNb therapy in multiple sclerosis patients.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 7, p. 894, doi. 10.1177/1352458514555786
- By:
- Publication type:
- Article
Towards a better understanding of pseudoatrophy in the brain of multiple sclerosis patients.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
Cortical lesion counts by double inversion recovery should be part of the MRI monitoring process for all MS patients: Yes.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 5, p. 537, doi. 10.1177/1352458514526084
- By:
- Publication type:
- Article
MRI measures should be a primary outcome endpoint in Phase III randomized, controlled trials in multiple sclerosis: Yes.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 3, p. 280, doi. 10.1177/1352458513507360
- By:
- Publication type:
- Article
Relevance of hypointense brain MRI lesions for long-term worsening of clinical disability in relapsing multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 2, p. 214, doi. 10.1177/1352458513494490
- By:
- Publication type:
- Article
Isoprostanes in clinically isolated syndrome and early multiple sclerosis as biomarkers of tissue damage and predictors of clinical course.
- Published in:
- Multiple Sclerosis Journal, 2013, v. 19, n. 4, p. 411, doi. 10.1177/1352458512457721
- By:
- Publication type:
- Article
The radiologically isolated syndrome dilemma: just an incidental radiological finding or presymptomatic multiple sclerosis?
- Published in:
- Multiple Sclerosis Journal, 2013, v. 19, n. 3, p. 257, doi. 10.1177/1352458512460418
- By:
- Publication type:
- Article
Modelling the distribution of cortical lesions in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 2, p. 229, doi. 10.1177/1352458511414965
- By:
- Publication type:
- Article
Magnetic resonance active lesions as individual-level surrogate for relapses in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2011, v. 17, n. 5, p. 541, doi. 10.1177/1352458510391837
- By:
- Publication type:
- Article